The sigma-1 receptor behaves as an atypical auxiliary subunit to modulate the functional characteristics of Kv1.2 channels expressed in HEK293 cells.
Cells, Cultured
Electrophysiological Phenomena
/ drug effects
HEK293 Cells
Humans
Ion Channel Gating
/ physiology
Kv1.2 Potassium Channel
/ drug effects
Patch-Clamp Techniques
/ methods
Phenazocine
/ analogs & derivatives
Receptors, sigma
/ agonists
Shaker Superfamily of Potassium Channels
/ physiology
Sigma-1 Receptor
Kvβ subunit
apFRET
ion channel biophysics
motor neuron disease
voltage-clamp electrophysiology
Journal
Physiological reports
ISSN: 2051-817X
Titre abrégé: Physiol Rep
Pays: United States
ID NLM: 101607800
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
28
02
2019
revised:
17
05
2019
accepted:
25
05
2019
entrez:
22
6
2019
pubmed:
22
6
2019
medline:
6
5
2020
Statut:
ppublish
Résumé
Expression of Kv1.2 within Kv1.x potassium channel complexes is critical in maintaining appropriate neuronal excitability and determining the threshold for action potential firing. This is attributed to the interaction of Kv1.2 with a hitherto unidentified protein that confers bimodal channel activation gating, allowing neurons to adapt to repetitive trains of stimulation and protecting against hyperexcitability. One potential protein candidate is the sigma-1 receptor (Sig-1R), which regulates other members of the Kv1.x channel family; however, the biophysical nature of the interaction between Sig-1R and Kv1.2 has not been elucidated. We hypothesized that Sig-1R may regulate Kv1.2 and may further act as the unidentified modulator of Kv1.2 activation. In transiently transfected HEK293 cells, we found that ligand activation of the Sig-1R modulates Kv1.2 current amplitude. More importantly, Sig-1R interacts with Kv1.2 in baseline conditions to influence bimodal activation gating. These effects are abolished in the presence of the auxiliary subunit Kvβ2 and when the Sig-1R mutation underlying ALS16 (Sig-1R-E102Q), is expressed. These data suggest that Kvβ2 occludes the interaction of Sig-1R with Kv1.2, and that E102 may be a residue critical for Sig-1R modulation of Kv1.2. The results of this investigation describe an important new role for Sig-1R in the regulation of neuronal excitability and introduce a novel mechanism of pathophysiology in Sig-1R dysfunction.
Identifiants
pubmed: 31222975
doi: 10.14814/phy2.14147
pmc: PMC6586770
doi:
Substances chimiques
KCNAB2 protein, human
0
Kv1.2 Potassium Channel
0
Receptors, sigma
0
Shaker Superfamily of Potassium Channels
0
SK&F 10047
7619-35-4
Phenazocine
J0ND6N0AQC
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14147Subventions
Organisme : CIHR
ID : CIHR # PJT-156089
Pays : Canada
Informations de copyright
© 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of The Physiological Society and the American Physiological Society.
Références
Handb Exp Pharmacol. 2017;244:109-130
pubmed: 28275909
Cell Death Differ. 2017 Oct;24(10):1655-1671
pubmed: 28622300
Biochem J. 2015 Mar 1;466(2):263-271
pubmed: 25510962
J Biol Chem. 2014 Jul 18;289(29):20333-44
pubmed: 24847081
Neuron. 1996 Apr;16(4):843-52
pubmed: 8608002
Epilepsia. 2012 Jun;53 Suppl 1:134-41
pubmed: 22612818
J Physiol. 1996 Jun 15;493 ( Pt 3):625-33
pubmed: 8799886
J Biol Chem. 1996 Mar 22;271(12):7084-9
pubmed: 8636142
Clin Neurophysiol. 2006 Jul;117(7):1444-8
pubmed: 16765084
Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):E6562-70
pubmed: 26554014
Oncotarget. 2017 Jul 26;8(35):59345-59358
pubmed: 28938641
Brain Res. 2012 May 3;1452:1-9
pubmed: 22433979
Trends Neurosci. 2012 Dec;35(12):762-71
pubmed: 23102998
Mol Neurobiol. 2018 Feb;55(2):1410-1418
pubmed: 28160214
Ann Neurol. 2016 Oct;80(4):
pubmed: 27543892
Trends Pharmacol Sci. 2010 Dec;31(12):557-66
pubmed: 20869780
Neuroscience. 2016 Sep 7;331:148-57
pubmed: 27339730
Brain Res Bull. 2018 Jun;140:318-333
pubmed: 29870780
J Med Chem. 2013 Dec 27;56(24):9809-19
pubmed: 23964901
J Neurosci. 1997 Nov 1;17(21):8246-58
pubmed: 9334400
Ann Neurol. 2010 Nov;68(5):639-49
pubmed: 21031579
Child Neurol Open. 2016 Sep 26;3:2329048X16669912
pubmed: 28503617
J Biol Chem. 1997 Nov 7;272(45):28232-6
pubmed: 9353274
Nature. 1994 May 26;369(6478):289-94
pubmed: 8183366
Biochemistry. 2007 Mar 20;46(11):3532-42
pubmed: 17315983
Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12607-12
pubmed: 14569011
Biochim Biophys Acta. 2014 Dec;1840(12):3320-34
pubmed: 25175561
Protein Cell. 2018 Aug;9(8):733-737
pubmed: 28929457
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Sci Rep. 2015 Jun 02;5:10689
pubmed: 26033680
J Pharmacol Sci. 2015 Jan;127(1):36-41
pubmed: 25704016
J Neurosci. 2015 Feb 25;35(8):3515-24
pubmed: 25716850
Neuroscience. 2010 May 5;167(2):247-55
pubmed: 20167253
J Physiol. 2000 Aug 1;526 Pt 3:527-39
pubmed: 10922005
Oncotarget. 2017 May 16;8(31):51317-51330
pubmed: 28881650
Mol Pharmacol. 2016 Sep;90(3):238-53
pubmed: 27418673
Neuroscience. 2010 Jun 2;167(4):1004-13
pubmed: 20302917
J Pharmacol Exp Ther. 1999 Apr;289(1):321-8
pubmed: 10087020
Cell Rep. 2014 Apr 10;7(1):1-11
pubmed: 24703839
J Physiol. 2007 Jan 1;578(Pt 1):143-57
pubmed: 17068104
Hum Mol Genet. 2016 Sep 1;25(17):3741-3753
pubmed: 27402882
J Neurophysiol. 2007 Sep;98(3):1501-25
pubmed: 17634333
Exp Neurol. 2011 Dec;232(2):149-53
pubmed: 21906595
Neuron. 2002 Apr 25;34(3):399-410
pubmed: 11988171
Cell Death Dis. 2014 Jun 12;5:e1290
pubmed: 24922074
Nat Rev Neurosci. 2006 Sep;7(9):710-23
pubmed: 16924260
Channels (Austin). 2016;10(2):158-66
pubmed: 26646078
Ann Neurol. 2011 Dec;70(6):913-9
pubmed: 21842496
J Neurochem. 1986 Apr;46(4):1032-41
pubmed: 3005501
Neuroscience. 2013 Jun 14;240:129-34
pubmed: 23458708
Neuron. 1996 Feb;16(2):455-63
pubmed: 8789960
Nature. 2016 Apr 28;532(7600):527-30
pubmed: 27042935
Life Sci. 2013 Apr 19;92(13):747-51
pubmed: 23454168
J Physiol. 1999 Jun 1;517 ( Pt 2):391-406
pubmed: 10332090
Ann N Y Acad Sci. 1999 Apr 30;868:344-55
pubmed: 10414304
Eur J Pharmacol. 1988 Apr 27;149(1-2):171-4
pubmed: 2840298
Physiol Rev. 2010 Apr;90(2):755-96
pubmed: 20393197
PLoS One. 2018 Jan 2;13(1):e0183585
pubmed: 29293509
Science. 2000 Jul 7;289(5476):123-7
pubmed: 10884227
Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2451-5
pubmed: 10051663
Biophys J. 2007 Dec 15;93(12):4173-86
pubmed: 17766348
Cell. 2007 Nov 2;131(3):596-610
pubmed: 17981125
J Physiol. 2002 Jun 15;541(Pt 3):673-83
pubmed: 12068032
J Neurol Neurosurg Psychiatry. 2012 Jul;83(7):734-8
pubmed: 22566594
Cell. 2013 Jan 17;152(1-2):236-47
pubmed: 23332758
J Pharmacol Exp Ther. 2005 Jun;313(3):1387-96
pubmed: 15764734
Mol Psychiatry. 2020 Mar;25(3):680-691
pubmed: 29880884
Am J Physiol Heart Circ Physiol. 2013 Feb 15;304(4):H589-99
pubmed: 23241319
Biochemistry. 2014 May 13;53(18):2993-3003
pubmed: 24766040
Physiol Rep. 2019 Jul;7(12):e14147
pubmed: 31222975
Neurology. 2015 Jun 16;84(24):2430-7
pubmed: 26078401
Brain. 2006 Apr;129(Pt 4):953-62
pubmed: 16467388
Cell Stem Cell. 2014 Jun 5;14(6):781-95
pubmed: 24704492
Mol Pharmacol. 1994 Jun;45(6):1227-34
pubmed: 7517498
Eur J Pharmacol. 2010 Sep 1;641(1):23-8
pubmed: 20546722
Hum Mol Genet. 2013 Apr 15;22(8):1581-600
pubmed: 23314020
J Biol Chem. 1997 Oct 10;272(41):25824-31
pubmed: 9325312